GLP-1 provoked severe hypoglycemia in an individual with type 2 diabetes and a Benign insulinoma

Diabetes Care

Volumn 37, Issue 8, 2014, Pages

  Ruby, Ronald J ^a   Armato, John P ^a   Pyke, Charles ^b   Peters, Anne L ^c  

^a Pacific Coast Medical Group   (United States)

^b NOVO NORDISK A S   (Denmark)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN 19; GLUCAGON; GLUCOSE; INSULIN; LIRAGLUTIDE; METFORMIN PLUS PIOGLITAZONE; PANCREAS POLYPEPTIDE; SOMATOSTATIN; GLUCAGON LIKE PEPTIDE 1; GLUCAGON RECEPTOR; GLUCAGON-LIKE PEPTIDE-1 RECEPTOR;

ADULT; CARBOHYDRATE DIET; CASE REPORT; CONFUSION; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPOGLYCEMIA; IMMUNOREACTIVITY; INSULIN BLOOD LEVEL; INSULINOMA; LETTER; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PANCREAS DISEASE; PANCREAS ISLET BETA CELL; PANCREAS RESECTION; PANCREATIC MASS; PROTEIN EXPRESSION; AGONISTS; ANALOGS AND DERIVATIVES; BLOOD; CHEMICALLY INDUCED; COMPLICATION; DIABETES MELLITUS, TYPE 2; PANCREATIC NEOPLASMS; SEVERITY OF ILLNESS INDEX;

DIABETES MELLITUS, TYPE 2; FEMALE; GLUCAGON-LIKE PEPTIDE 1; HUMANS; HYPOGLYCEMIA; INSULIN; INSULINOMA; MIDDLE AGED; PANCREATIC NEOPLASMS; RECEPTORS, GLUCAGON; SEVERITY OF ILLNESS INDEX;

EID: 84905028829     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc14-0514     Document Type: Letter

References (3)

1. Armato J, DeFronzo RA, Abdul-Ghani M, Ruby R. Successful treatment of prediabetes in clinical practice: targeting insulin resistance and β-cell dysfunction. Endocr Pract 2012; 18: 342-350
2. Pyke C, Knudsen LB The glucagon-like peptide-1 receptordor not? Endocrinology 2013; 154: 4-8
3. Wild D, Christ E, Caplin M.E., et al. GLP-1 versus somatostatin receptor targeting reveals 2 distinct forms of malignant insulinomas. J Nucl Med 2011; 52: 1073-1078